Funding
Cancer
RECRUITMENT, CANCER
This work was supported by Bayer through an investigator-initiated study grant. ICR-CTSU also receives program grant funding from Cancer Research UK (C1491/A15955, C1491/A25351). Trial recruitment was facilitated at participating sites by the National Institute for Health Research (NIHR)–funded National Cancer Research Network. A.T. acknowledges Cancer Research UK RadNet grants No. C7224/A28724 and C33589/A28284. This paper represents independent research supported by the NIHR Biomedical Research Centre and the Clinical Research Facilities at the Royal Marsden NHS Foundation Trust and the ICR, London. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.